Computational Imaging Group

Dr Blackledge's research seeks to provide clinical imaging methodologies for evaluating and understanding response mechanisms associated with novel therapeutics for bone metastases.

 

Dr Matthew Blackledge

Group Leader:

Computational Imaging Matthew Blackledge, Group Leader in Radiotherapy and Imaging

Dr Matthew Blackledge is leader of the Computational Imaging Group in the Division of Radiotherapy and Imaging.

See profile

Researchers in this group

.

Phone: +44 20 8722 4388

Email: [email protected]

Location: Sutton

See profile

.

Phone: +44 20 3437 6396

Email: [email protected]

Location: Sutton

See profile

.

Phone: +44 20 3437 6454

Email: [email protected]

Location: Sutton

See profile

Dr Matthew Blackledge's group have written 80 publications

Most recent new publication 6/2024

See all their publications

Recent discoveries from this group

Stained tissue section of a bowel tumour
Targeted immunotherapy could boost radiotherapy response

08/03/21

Profiling the ‘immune landscape’ of patient’s tumours reveals who will most benefit from radiotherapy with potential immunotherapy in bowel cancer. Tumours which are chronically Inflamed before treatment could be made more susceptible using targeted immunotherapies
See full story